NCDR CathPCI Registry Safley JACC CV Interventions Glycoprotein Inhibition in PCI for ACS Study Slide
Description: Slide representing findings from ”Impact of Glycoprotein 2b/3a Inhibition in Contemporary Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights from the National Cardiovascular Data Registry,” by David M. Safley, MD, FACC, published in JACC: Cardiovascular Interventions based on research from the CathPCI Registry.
Date: October 19, 2015
Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Invasive Cardiovascular Angiography and Intervention, Stable Ischemic Heart Disease, Anticoagulation Management and ACS, Interventions and ACS, Chronic Angina
Keywords: Acute Coronary Syndrome, Angina Pectoris, Angina, Stable, Anticoagulants, Heparin, Hirudins, Myocardial Infarction, Peptide Fragments, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Registries, Risk, Risk Reduction Behavior, Risk Adjustment, National Cardiovascular Data Registries, CathPCI Registry